Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Shares Outstanding (Weighted Average) (2016 - 2025)

Orthofix Medical's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $39.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 3.85% year-over-year to $39.6 million, compared with a TTM value of $39.6 million through Dec 2025, up 3.85%, and an annual FY2025 reading of $39.6 million, up 3.85% over the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $39.6 million at Orthofix Medical, roughly flat from $39.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $39.6 million in Q4 2025, with the low at $19634.0 in Q3 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $22.1 million, with a median of $28.3 million recorded in 2022.
  • Year-over-year, Shares Outstanding (Weighted Average) crashed 99.9% in 2022 and then soared 182011.39% in 2023.
  • Tracing OFIX's Shares Outstanding (Weighted Average) over 5 years: stood at $19.7 million in 2021, then increased by 1.85% to $20.1 million in 2022, then soared by 83.15% to $36.7 million in 2023, then rose by 3.82% to $38.1 million in 2024, then increased by 3.85% to $39.6 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Shares Outstanding (Weighted Average) are $39.6 million (Q4 2025), $39.5 million (Q3 2025), and $39.3 million (Q2 2025).